Drug · DIN 02420104
NEUPOGEN
0.5 ML PREFILLED SYRINGE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 28, 2016; first marketed January 28, 2016.
- Drug Identification Number (DIN)
- 02420104
- Company (DIN owner)
- Amgen Canada IncMississauga, Ontario, Canada
- Schedule
- Prescription; Schedule d
- Dosage form
- Solution
- Route
- Subcutaneous; Intravenous
- Therapeutic class (ATC)
- Filgrastim L03AA02
- Class
- Human
- Record last updated
- July 31, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| FILGRASTIM | 600 MCG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 28, 2014: NOC 15162Supplement to a New Drug Submission (SNDS) · New drug product presentation, prefilled syringe, new strength
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “neupogen”. A notice may cover another product or only some lots: read it to see what it covers.
- Neupogen vials; Out of specification (Stability)March 27, 2025 · Biologic or vaccine · Product quality · Type III
Other DINs named NEUPOGEN
- DIN 01968017 · Marketed
- DIN 02420112 · Marketed